This case study shares the journey of a Chinese patient with astrocytic glioma (WHO Grade 3) who sought advanced treatment guidance through Medebound HEALTH’s international telemedicine platform. By connecting with Professor Patrick, Director of Neuro-Oncology at Harvard’s Dana-Farber Cancer Institute, the family received recommendations for advanced genetic testing, targeted therapies, immunotherapy, and clinical trial opportunities. The consultation provided new hope.